-George Perry Researcher Activity Profile

Research Author Detailed Information 

George Perry Publication Rate By Year

George Perry has published 2 paper(s) in 2005, 4 paper(s) in 2006, 26 paper(s) in 2007, 9 paper(s) in 2008, for a total of 41 research publications in total.

George G Perry Author Information

LAST NAME: perry

FIRST NAME: george

INITIALS: G

AFFILIATION:

Papers

George Perry's Publication Record

1. Redox metals and oxidative abnormalities in human prion diseases. Year Published: 2005
Institute of Pathology, Case Western Reserve University, 2085 Adelbert Road, Cleveland, OH 44106, USA.
2. Heme deficiency in Alzheimer's disease: a possible connection to porphyria. Year Published: 2006
3. Targeting gonadotropins: an alternative option for Alzheimer disease treatment. Year Published: 2006
4. Neurodegenerative diseases: mechanisms and therapies. Year Published: 2006
5. Oxidative damage to RNA in neurodegenerative diseases. Year Published: 2006
6. Increased expression of the remodeling- and tumorigenic-associated factor osteopontin in pyramidal neurons of the Alzheimer's disease brain. Year Published: 2007
Institute of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA.
7. Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts. Year Published: 2007
Center for Neuroscience and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal.
8. Increased autophagic degradation of mitochondria in Alzheimer disease. Year Published: 2007
Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
9. Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses. Year Published: 2007
Department of Pathology, Case Western Reserve University, 2103 Cornell Road, Cleveland, OH 44106, USA.
10. Signal transduction cascades associated with oxidative stress in Alzheimer's disease. Year Published: 2007
Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.
11. c-Jun phosphorylation in Alzheimer disease. Year Published: 2007
Department of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA.
12. Vascular oxidative stress in Alzheimer disease. Year Published: 2007
Department of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA.
13. Iron: the Redox-active center of oxidative stress in Alzheimer disease. Year Published: 2007
Department of Pathology, University of Maryland, Baltimore, MD, USA.
14. Oxidative stress is an early event in hydrostatic pressure induced retinal ganglion cell damage. Year Published: 2007
Hamilton Glaucoma Center and the Department of Ophthalmology, University of California San Diego, La Jolla, California 92037-0946, USA.
15. Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts. Year Published: 2007
Center for Neuroscience and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal.
16. Increased autophagic degradation of mitochondria in Alzheimer disease. Year Published: 2007
Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
17. Iron homeostasis is maintained in the brain, but not the liver, following mild hypoxia. Year Published: 2007
Institute of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
18. Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-beta peptide. Year Published: 2007
Hokkaido Institute of Public Health, Kita 19, Nishi 12, Kita-ku, Sapporo 060-0819, Japan.
19. Three histidine residues of amyloid-beta peptide control the redox activity of copper and iron. Year Published: 2007
Department of Chemistry, Asahikawa Medical College, Asahikawa 078-8510, Japan. nmasao@asahikawa-med. ac.jp
20. Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease. Year Published: 2007
Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.
21. Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-beta peptide. Year Published: 2007
Hokkaido Institute of Public Health, Kita 19, Nishi 12, Kita-ku, Sapporo 060-0819, Japan.
22. The contribution of luteinizing hormone to Alzheimer disease pathogenesis. Year Published: 2007
Department of Pathology, Case Western Reserve University, 2103 Cornell Road, Cleveland, Ohio 44106 USA. mark.smith@case.edu.
23. Redox metals and oxidative abnormalities in human prion diseases. Year Published: 2005
Institute of Pathology, Case Western Reserve University, 2085 Adelbert Road, Cleveland, OH 44106, USA.
24. Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts. Year Published: 2007
Center for Neuroscience and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal.
25. Iron homeostasis is maintained in the brain, but not the liver, following mild hypoxia. Year Published: 2007
Institute of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
26. Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-beta peptide. Year Published: 2007
Hokkaido Institute of Public Health, Kita 19, Nishi 12, Kita-ku, Sapporo 060-0819, Japan.
27. Three histidine residues of amyloid-beta peptide control the redox activity of copper and iron. Year Published: 2007
Department of Chemistry, Asahikawa Medical College, Asahikawa 078-8510, Japan. nmasao@asahikawa-med. ac.jp
28. The contribution of luteinizing hormone to Alzheimer disease pathogenesis. Year Published: 2007
Department of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA. mark.smith@case.edu
29. Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. Year Published: 2008
Department of Experimental Medicine and Oncology, University of Torino, Torino, Italy. elena.tamagno@unito.it
30. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Year Published: 2008
Life Sciences Institute, University of Michigan, Ann Arbor, Michigan 48109-2216, USA. klionsky@umich.edu
31. Oxidative stress and neurotoxicity. Year Published: 2008
Departments of Chemistry, Pathology, and Environmental Health Sciences, Case Western Reserve University, Cleveland, Ohio 44106, and College of Sciences, University of Texas at San Antonio, San Antonio, Texas 78249 LMS3@case.edu.
32. Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease. Year Published: 2007
Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.
33. Evidence for the role of luteinizing hormone in Alzheimer disease. Year Published: 2008
Department of Pathology, Case Western Reserve University, 2103 Cornell Road, Cleveland, Ohio 44106, USA. mark.smith@case.edu.
34. Increased autophagic degradation of mitochondria in Alzheimer disease. Year Published: 2007
Department of Pathology, Case Western Reserve University, Cleveland, Ohio, USA.
35. Evidence for the role of luteinizing hormone in Alzheimer disease. Year Published: 2008
Department of Pathology, Case Western Reserve University, 2103 Cornell Road, Cleveland, Ohio 44106, USA.
36. Insights into amyloid-beta-induced mitochondrial dysfunction in Alzheimer disease. Year Published: 2007
Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.
37. The contribution of luteinizing hormone to Alzheimer disease pathogenesis. Year Published: 2007
Department of Pathology, Case Western Reserve University, Cleveland, Ohio 44106, USA. mark.smith@case.edu
38. Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. Year Published: 2008
Department of Experimental Medicine and Oncology, University of Torino, Torino, Italy. elena.tamagno@unito.it
39. Alzheimer disease and the role of free radicals in the pathogenesis of the disease. Year Published: 2008
College of Sciences, University of Texas at San Antonio, San Antonio, Texas 78249, USA. george.perry@utsa.edu.
40. Evidence for the role of luteinizing hormone in Alzheimer disease. Year Published: 2008
Department of Pathology, Case Western Reserve University, 2103 Cornell Road, Cleveland, Ohio 44106, USA.
41. Nucleic acid oxidation in Alzheimer disease. Year Published: 2008
Center for Neuroscience and Cell Biology, Institute of Physiology-Faculty of Medicine, University of Coimbra, Coimbra, Portugal.